An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection

Previously reported prognostic signatures for predicting the prognoses of postsurgical hepatocellular carcinoma (HCC) patients are commonly based on predefined risk scores, which are hardly applicable to samples measured by different laboratories. To solve this problem, using gene expression profile...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Ao, Lu, Song, Xuekun, Li, Xiangyu, Tong, Mengsha, Guo, You, Li, Jing, Li, Hongdong, Cai, Hao, Li, Mengyao, Guan, Qingzhou, Yan, Haidan, Guo, Zheng
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2016
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029687/
https://ncbi.nlm.nih.gov/pubmed/27006471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8212
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge